Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Fund Letter | Nathan Fredrick, CFARiverwater Micro Opportunities Strategy | Lifeway Foods $LWAY• NASDAQ | Food ProductsFood Products | Riverwater Micro Opportunities Strategy - LWAY We added Lifeway Foods (LWAY) in April, the dominant U.S. producer of kefir. Lifeway reported record... | NEUTRAL | View Pitch → |
| Jan 28, 2026 | Fund Letter | Randy GwirtzmanBaron Discovery Fund | Health Care TechnologyHealth Care Technology | Baron Discovery Fund 2025 Q4 (WAY) We initiated a position in Waystar Holding Corp., which provides a full spectrum of revenue cycle management software to health care providers. The company services... | BULL | View Pitch → | |
| Nov 28, 2025 | Fund Letter | Jason WhiteArtisan Global Discovery | Health Care TechnologyHealth Care Technology | Artisan Global Discovery 2025 Q3 (WAY) Waystar is a leading cloud-based revenue cycle management platform that supports over 30,000 health care organizations, including 16 of the top 20 US hospitals. We initiated a... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.